Clinical Trials Logo

Clinical Trial Summary

Yunnan Baiyao has been treating all kinds of wounds for 120 years, but the evidence of Evidence-based medicine that is truly convincing is insufficient, making its best application method unclear. This study explored the possible indications and use methods of Yunnan Baiyao in different stages of Diabetic foot, and obtained Evidence-based medicine evidence of clinical efficacy. Obtain the discarded tissues of Diabetic foot patients in the treatment and control groups of Yunnan Baiyao after wound debridement, conduct Transcriptome (BulkRNA seq) analysis and detection on the wound tissues, and analyze the related signal pathways and functional genes with significant differences, to help clarify the possible treatment targets of Yunnan Baiyao.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06197412
Study type Interventional
Source Peking University Third Hospital
Contact
Status Not yet recruiting
Phase Phase 4
Start date January 8, 2024
Completion date March 31, 2026